Acute Pericarditis: Update.
Emilia LazarouPanagiotis TsioufisCharalambos VlachopoulosCostas TsioufisGeorge LazarosPublished in: Current cardiology reports (2022)
In recurrent acute pericarditis, autoinflammation has been included among causative mechanisms restricting the vague diagnoses of "idiopathic" pericarditis. Cardiac magnetic resonance that detects ongoing pericardial inflammation may guide treatment in difficult-to-treat patients. Development of risk scores may assist identification of patients at high risk for complicated pericarditis, who should be closely monitored and aggressively treated. Treatment with IL-1 inhibitors has been proven efficacious in recurrent forms with a good safety profile. Finally, acute pericarditis has recently attracted great interest as it has been reported among side effects post COVID-19 vaccination and may also complicate SARS-CoV-2 infection. Recent advancements in acute pericarditis have contributed to a better understanding of the disease allowing a tailored to the individual patient approach. However, there are still unsolved questions that require further research.
Keyphrases
- liver failure
- end stage renal disease
- magnetic resonance
- respiratory failure
- newly diagnosed
- ejection fraction
- chronic kidney disease
- aortic dissection
- prognostic factors
- peritoneal dialysis
- coronavirus disease
- sars cov
- oxidative stress
- heart failure
- intensive care unit
- hepatitis b virus
- left ventricular
- atrial fibrillation
- extracorporeal membrane oxygenation
- combination therapy
- contrast enhanced